BUD
Anheuser-Busch InBev SA/NV
There isn't enough reported data to score BUD yet.
CELH
Celsius Holdings, Inc.
CELH's fundamentals are strong and it looks cheap: trading at 35x earnings, less than half its usual 142x. Analysts expect strong earnings growth, though they disagree widely on how much.
BUD Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Unavailable | |
| Unavailable | |
| Unavailable |
There isn't enough reported data to rate BUD's fundamentals.
CELH Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Strong |
CELH's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
BUD PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 17x | N/A | N/A |
| Current | 18x | $83.85 | — |
| Fair | 21x | N/A | N/A |
| Expensive | 26x | N/A | N/A |
Historical ranges are pointers, not guarantees.
BUD's PE is 18x, but its earnings don't support one, so it isn't a reliable read right now.
CELH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 21x | $31.89 | — |
| Current | 35x | $31.89 | — |
| Cheap | 40x | $35.95 | +13% |
| Fair | 141x | $127 | +299% |
| Expensive | 650x | $585 | +1735% |
Historical ranges are pointers, not guarantees.
CELH's PE is in its cheap range at 35x. If earnings grow as analysts expect, today's price would be 21x next year's earnings.
BUD Forward outlook
There aren't enough analyst estimates for BUD to show an outlook.
CELH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for CELH, with profitability improving. However, they disagree widely on these estimates.
BUD Earnings Per Share
BUD and CELH do not have enough comparable growth data to identify a winner.
CELH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.53 | +70% |
| Q3 2026 | $0.90 | +718% |
| Q2 2026 | $0.24 | -37% |
| Q1 2026 | $0.43 | +30% |
| Q4 2025 | $0.25 | -44% |
| Q3 2025 | $0.11 | -85% |
| Q2 2025 | $0.38 | -62% |
| Q1 2025 | $0.33 | -64% |
| Q4 2024 | $0.45 | -42% |
CELH earned $0.90 per share over the past year, about eight times what it earned the year before.
BUD Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $31.9B | +6.4% |
| Q4 2025 | $30.7B | +2.7% |
| Q2 2025 | $30B | +0.4% |
| Q4 2024 | $29.9B | -0.5% |
| Q2 2024 | $29.9B | +1.9% |
| Q4 2023 | $30B | +1% |
| Q2 2023 | $29.3B | +4.7% |
| Q4 2022 | $29.8B | +4.5% |
BUD's revenue has grown year over year for 11 quarters in a row: $31.9B last quarter, up 6.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 27% | +2 points |
| Q4 2025 | 26% | +2.4 points |
| Q2 2025 | 50% | +26 points |
| Q4 2024 | 27% | +1.7 points |
| Q2 2024 | 25% | +0.3 points |
| Q4 2023 | 23% | -2.2 points |
| Q2 2023 | 24% | -1.3 points |
| Q4 2022 | 25% | -3.3 points |
BUD has the edge over CELH on profitability, with a higher operating margin.
CELH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $847.2M | +17% |
| Q2 2026 | $817.9M | +11% |
| Q1 2026 | $782.6M | +138% |
| Q4 2025 | $721.6M | +117% |
| Q3 2025 | $725.1M | +173% |
| Q2 2025 | $739.3M | +84% |
| Q1 2025 | $329.3M | -7.4% |
| Q4 2024 | $332.2M | -4.4% |
CELH has the edge over BUD in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +31 points |
| Q2 2026 | 9.2% | -10 points |
| Q1 2026 | 18% | +2 points |
| Q4 2025 | 3.6% | +9.2 points |
| Q3 2025 | -11% | -9.8 points |
| Q2 2025 | 19% | -4.1 points |
| Q1 2025 | 16% | -7.6 points |
| Q4 2024 | -5.6% | -23 points |
CELH's operating margin was 20% last quarter, up 31 points from the same quarter a year ago.
BUD Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $3.8B | +193% |
| Q4 2025 | $9.9B | -4.2% |
| Q2 2025 | $1.3B | +58% |
| Q4 2024 | $10.4B | +13% |
| Q2 2024 | $831.7M | +$2B |
| Q4 2023 | $9.1B | +15% |
| Q2 2023 | -$1.2B | -$1.1B |
| Q4 2022 | $8B | +7.6% |
BUD generated $25.4B in free cash flow over the past year, up 52% from the year before.
CELH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $127.7M | -60% |
| Q2 2026 | $205.5M | +479% |
| Q1 2026 | $65.8M | -32% |
| Q4 2025 | -$130M | -285% |
| Q3 2025 | $321.5M | +3599% |
| Q2 2025 | $35.5M | +17% |
| Q1 2025 | $96.4M | -26% |
| Q4 2024 | $70.3M | +16394% |
CELH still generates free cash flow, though less than at its 2025 peak: $269M over the past year.
BUD Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +10% | +181M shares |
| 1 year | -3.2% | -65.3M shares |
| 3 years | +0.3% | +6.6M shares |
| 5 years | +20% | +336M shares |
| Available history | +23% | +376M shares |
BUD has the edge over CELH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $1.3B |
| Q4 2025 | $400M |
| Q2 2025 | $1.9B |
| Q4 2024 | $99M |
| Q2 2024 | $836.7M |
| Q2 2023 | — |
| Q2 2022 | — |
| Q2 2021 | — |
CELH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -2M shares |
| 1 year | -1.1% | -2.9M shares |
| 3 years | +7.4% | +17.6M shares |
| 5 years | +8.3% | +19.5M shares |
| Available history | +32% | +62.4M shares |
CELH has 255M diluted shares, down 1.1% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $300,000 |
| Q2 2026 | $1M |
| Q1 2026 | $8.8M |
| Q4 2025 | $2.5M |
| Q3 2025 | $448,000 |
| Q2 2025 | $879,000 |
| Q1 2025 | $1.9M |
| Q4 2024 | $603,000 |
CELH spent $13M buying back its own shares over the past year, about three times what it spent the year before.
BUD Net Leverage
BUD's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CELH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | 1.6x | Healthy |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | -7.3x | Net Cash |
| Q4 2024 | -5.5x | Net Cash |
CELH has more cash than debt.
BUD Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.7 | Neutral |
| Stochastic | 74.5 | Neutral |
BUD's weekly RSI is 57 (neutral) and its Stochastic is 75 (neutral).
CELH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.3 | Neutral |
| Stochastic | 56.8 | Neutral |
CELH's weekly RSI is 51 (neutral) and its Stochastic is 57 (neutral).
BUD PE vs Consumer Defensive Sector
| Metric | BUD | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 19x | 8.3% below |
| PE % | 21 | 18 | 3 pts above |
BUD has the edge over CELH on valuation relative to its sector.
CELH PE vs Consumer Defensive Sector
| Metric | CELH | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 19x | 82% above |
| PE % | 11 | 18 | 7 pts below |
CELH is trading at 35x earnings, a 82% premium to the Consumer Defensive sector's median of 19x.
BUD Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $80.5 | 4.2% above |
| 20 week MA | $80.6 | 4% above |
| 50 week MA | $76.5 | 9.6% above |
| 100 week MA | $68.8 | 22% above |
| 200 week MA | $64.5 | 30% above |
BUD has the edge over CELH on trend strength, trading above more of its moving averages.
CELH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.1 | 9.4% above |
| 20 week MA | $29.6 | 7.8% above |
| 50 week MA | $36.1 | 12% below |
| 100 week MA | $38.8 | 18% below |
| 200 week MA | $44.6 | 29% below |
CELH has bounced recently, but its long-term trend is still down: it's above its 8- and 20-week averages, but 29% below its 200-week average.
BUD Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $83.1 | $70.6 | -15% |
| 2021 | $70.6 | $60.8 | -14% |
| 2022 | $60.8 | $60.4 | -0.7% |
| 2023 | $60.4 | $64.6 | +7% |
| 2024 | $64.6 | $50.4 | -22% |
| 2025 | $50.4 | $64.2 | +28% |
| 2026 YTD | $64.2 | $83.9 | +31% |
BUD has the edge over CELH on returns for 2026, with the stronger performance.
CELH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $1.58 | $14.7 | +832% |
| 2021 | $14.7 | $24.9 | +69% |
| 2022 | $24.9 | $35.6 | +43% |
| 2023 | $35.6 | $54.5 | +53% |
| 2024 | $54.5 | $26.5 | -51% |
| 2025 | $26.5 | $45.6 | +72% |
| 2026 YTD | $45.6 | $31.9 | -30% |
CELH's yearly returns have swung widely, from +832% in 2020 to −51% in 2024. It's down 30% so far in 2026.